1. Kobayashi H, Uekuri C, Akasaka J, Ito F, Shigemitsu A, Koike N, Shigetomi H.  The biology of uterine sarcomas: A review and update. Mol Clin Oncol. 2013;1(4):599-609.

2. Szukala SA, Marks JR, Burchette JL, Elbendary AA, Krigman HR. Co-expression of p53 by epithelial and stromal elements in carcinosarcoma of the female genital tract: an immunohistochemical study of 19 cases. Int J Gynecol Cancer. 1999;9(2):131-13

3.McCluggage WG.  Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer. 2002;12(6):687-90.

4.Cibas ES and Ducatman BS. Cytolology. Diagnostic Principles and Clinical Correlation.  Third edition. Saunders  2009; P54.

5.Garg G, Yee C, Schwartz K, Mutch DG, Morris RT, Powell MA.  Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis. Gynecol Oncol. 2014;133(2):242-9.

6.Gupta N, Dudding N, Smith JH.  Eight cases of malignant mixed Müllerian tumor (carcinosarcoma) of the uterus: findings in SurePath™ cervical cytology. Diagn Cytopathol. 2014;42(2):165-9.

7.Mourad WA, Sneige N, Katz RL, Caraway NP, Fanning TV. Fine-needle aspiration cytology of recurrent and metastatic mixed mesodermal tumors. Diagn Cytopathol. 1994;11(4):328-32.

8.Penson RT, Goodman A, Growdon WB, Borger DR, Lee SI, Oliva E. Case records of the Massachusetts General Hospital. Case 14-2013. A 70-year-old woman with vaginal bleeding. N Engl J Med. 2013;368(19):1827-35

9.McCluggage WG, Colgan T, Duggan M, Hacker NF, Mulvany N, Otis C, Wilkinson N, Zaino RJ, Hirschowitz L.  Data set for reporting of endometrial carcinomas: recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and Australasia. Int J Gynecol Pathol. 2013;32(1):45-65.